A Nebraska judge has determined that a biotech company seeking to purchase the shares of a trust established by its founder must pay $467 million for those shares, in what counsel for the plaintiffs say is one of the largest valuation disputes in the state court’s history.

On Tuesday, a judge from the District Court of Sarpy County, Nebraska, found that the Wayne L. Ryan Revocable Trust owned $467 million of the fair market value of the biomedical company Streck Inc., and that the trust was entitled to 12% prejudgment interest starting in late 2014. The ruling assigned more than $300 million over the defense’s competing valuation.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]